SENS3 Report: the GIFT Versus Cancer

September 17, 2007 | Source: The Methuselah Foundation Blog

At the third Strategies for Engineered Negligible Senescence conference (SENS3), Dr. Zheng Cui at the Comprehensive Cancer Center of Wake Forest University presented evidence of high-potency cancer-killing granulocytes in humans.

He plans to test the transfusion of granulocytes from highly cancer-resistant people into people with existing cancer — a potential therapy he calls “GIFT” (for “Granulocyte InFusion Therapy”).